Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
- PMID: 35210450
- PMCID: PMC8873444
- DOI: 10.1038/s41598-022-06555-3
Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
Abstract
The proliferation index (PI) is crucial in histopathologic diagnostics, in particular tumors. It is calculated based on Ki-67 protein expression by immunohistochemistry. PI is routinely evaluated by a visual assessment of the sample by a pathologist. However, this approach is far from ideal due to its poor intra- and interobserver variability and time-consuming. These factors force the community to seek out more precise solutions. Virtual pathology as being increasingly popular in diagnostics, armed with artificial intelligence, may potentially address this issue. The proposed solution calculates the Ki-67 proliferation index by utilizing a deep learning model and fuzzy-set interpretations for hot-spots detection. The obtained region-of-interest is then used to segment relevant cells via classical methods of image processing. The index value is approximated by relating the total surface area occupied by immunopositive cells to the total surface area of relevant cells. The achieved results are compared to the manual calculation of the Ki-67 index made by a domain expert. To increase results reliability, we trained several models in a threefold manner and compared the impact of different hyper-parameters. Our best-proposed method estimates PI with 0.024 mean absolute error, which gives a significant advantage over the current state-of-the-art solution.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.Breast Cancer. 2011 Oct;18(4):286-91. doi: 10.1007/s12282-009-0192-y. Epub 2010 Feb 9. Breast Cancer. 2011. PMID: 20143189
-
Automated assessment of Ki-67 proliferation index in neuroendocrine tumors by deep learning.APMIS. 2022 Jan;130(1):11-20. doi: 10.1111/apm.13190. Epub 2021 Nov 22. APMIS. 2022. PMID: 34741788 Free PMC article.
-
Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer.Lab Invest. 2024 May;104(5):100341. doi: 10.1016/j.labinv.2024.100341. Epub 2024 Jan 25. Lab Invest. 2024. PMID: 38280634
-
Ductal carcinoma in situ of the breast: current concepts and future directions.Arch Pathol Lab Med. 2013 Apr;137(4):462-6. doi: 10.5858/arpa.2012-0078-RA. Arch Pathol Lab Med. 2013. PMID: 23544935 Review.
-
Interobserver Variability in Ductal Carcinoma In Situ of the Breast.Am J Clin Pathol. 2020 Oct 13;154(5):596-609. doi: 10.1093/ajcp/aqaa077. Am J Clin Pathol. 2020. PMID: 32566938 Review.
Cited by
-
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications.Front Oncol. 2025 Jan 28;15:1467664. doi: 10.3389/fonc.2025.1467664. eCollection 2025. Front Oncol. 2025. PMID: 39959664 Free PMC article.
-
Deep learning applications in breast cancer histopathological imaging: diagnosis, treatment, and prognosis.Breast Cancer Res. 2024 Sep 20;26(1):137. doi: 10.1186/s13058-024-01895-6. Breast Cancer Res. 2024. PMID: 39304962 Free PMC article. Review.
-
Clinicopathologic characteristics of neuroendocrine tumors with assessment by digital image analysis for Ki-67 index with a focus on the gastroenteropancreatic tract: a single-center study.Int J Clin Exp Pathol. 2023 Sep 15;16(9):225-234. eCollection 2023. Int J Clin Exp Pathol. 2023. PMID: 37818384 Free PMC article.
-
Ki67 proliferation index in medullary thyroid carcinoma: a comparative study of multiple counting methods and validation of image analysis and deep learning platforms.Histopathology. 2023 Dec;83(6):981-988. doi: 10.1111/his.15048. Epub 2023 Sep 14. Histopathology. 2023. PMID: 37706239 Free PMC article.
-
Breaking Barriers: AI's Influence on Pathology and Oncology in Resource-Scarce Medical Systems.Cancers (Basel). 2023 Dec 2;15(23):5692. doi: 10.3390/cancers15235692. Cancers (Basel). 2023. PMID: 38067395 Free PMC article. Review.
References
-
- Lakshmi, S., Vijayasenan, D., Sumam, D. S., Sreeram, S. & Suresh, P. K. An Integrated Deep Learning Approach towards Automatic Evaluation of Ki-67 Labeling Index. In Proceedings of the TENCON 2019 : Technology, Knowledge, and Society : 17–20 October 2019, Grand Hyatt Kochi Bolgatti, Kerala, India. 2310–2314 (2019).
-
- Swiderska-Chadaj Z, Gallego J, Gonzalez-Lopez L, Bueno G. Detection of Ki67 hot-spots of invasive breast cancer based on convolutional neural networks applied to mutual information of H& E and Ki67 whole slide images. Appl. Sci. 2020;10:7761. doi: 10.3390/app10217761. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous